Results for shunt translation from English to Maltese

shunt regulator
regolatur tax-shunt

shunt thrombosis*
trombożi fix-xant

shunt thrombosis thrombocytosis
trombożi fix-shunt tromboċitożi

early shunt revision and
jistgħu jseħħu trombożi fix- xant, speċjalment f’ pazjenti li jkollhom tendenza għal pressjoni baxxa jew li l- fistuli bejn l- arterji u l- vini tagħhom juru komplikazzjonijiet (eż. stenosijiet, anewriżmi, eċċ.).

headache shunt thrombosis thrombocytosis
pressjoni għolja

intraventicular shunt, brain tumour, encephalitis.
shunt intraventrikulari, tumur tal-moħħ, enċefalite.

if you have been told you have a heart shunt
jekk qalulek li għandek mogħdija alternattiva għaċ-ċirkolazzjoni tad-demm (heart shunt)

or to prevent clotting of the arterio-venous shunt.
to l- użu ħażin ta ’ epoetin minn persuni b’ saħħithom jista ’ jwassal għal żieda eċċessiva fl- emoglobina u fl -

your doctor might prescribe acetylsalicylic acid or modify the shunt.
it-tabib tiegħek jista’ jippreskrivi acetylsalicylic acid jew jimmodifika x-shunt.

blood clots (thrombosis) may form in your dialysis shunt.
emboli tad-demm (trombożi) jistgħu jiffurmaw fix-shunt tad-dijalisi tiegħek.

if you have been told you have a right-to-left heart shunt.
jekk qalulek li għandek mogħdija għaċ-ċirkolazzjoni tad-demm mil-lemin għax-xellug

your doctor may check your shunt and prescribe a medicinal product to prevent thrombosis.
it-tabib tiegħek jista’ jiċċekkja x-xant tiegħek u jordnalek prodott mediċinali biex tiġi evitata trombożi.

the mean time between shunt palliation and first administration of study medicinal product was 20 days.
iż-żmien medju bejn id-devjazzjoni kirurġika ta’ għajnuna u l-ewwel għotja tal- prodott mediċinali taħt studju kien ta’ 20 ġurnata.

- occlusion in the connection between artery and vein (shunt thrombosis) may occur especially if
- okklużjoni fejn arterja tikkonnettja mal- vina (trombożi fix- xant) tista ’ sseħħ speċjalment jekk

early shunt revision and thrombosis prophylaxis by administration of acetylsalicylic acid, for example, is recommended in these patients.
reviżjoni bikrija tax-xant u profilassi tat-trombożi bl-għoti ta’ acetylsalicylic acid, per eżempju, huwa rakkomandat f’dawn il-pazjenti.

during haemodialysis, patients treated with dynepo may require increased anticoagulation treatment to prevent clotting of the arterio-venous shunt.
matul l-emodijaliżi, il-pazjenti kkurati b’dynepo jista’ jkollhom bżonn ta’ żieda fil-kura kontra l- koagulazzjoni biex jiġi evitat it-tagħqid tad-demm tas-shunt arterjo-venuża.

early shunt revision and thrombosis prophylaxis by administration of acetylsalicylic acid, for example, should be considered in chronic renal failure patients at risk of shunt thrombosis.
f’pazjenti b’insuffiċjenza kronika tal-kliewi li għandhom riskju ta’ shunt thrombosis, għandu jiġi ikkunsidrat li ssir reviżjoni bikrija ta’ shunts u lqugħ għat-trombożi billi jingħata acetylsalicylic acid, per eżempju.

the mean pulmonary vascular resistance was significantly reduced in the bosentan group (with a predominant effect observed in the subgroup of patients with bidirectional intracardiac shunt).
il-medja tar-reżistenza vaskulari pulmonari kienet imnaqqsa b’mod sinifikattiv fil-grupp ta’ bosentan (b’effett predominanti osservat fis- sottogrupp ta’ pazjenti b’shunt intrakardijaku bi-direzzjonali).

shunt thromboses may occur, especially in patients who have a tendency to hypotension or whose arteriovenous fistulae exhibit complications (e. g. stenoses, aneurisms), see section 4.4.
21 tista ’ sseħħ shunt thrombosis speċjalment f’ pazjenti li għandhom tendenza għal ipotensjoni jew dawk li għandhom kumplikazzjonijiet fil- fistulae arterjovenużi (eż. stenożi, anewriżmi), ara sezzjoni 4. 4.